Abbott Laboratories (BIT:1ABT)
Italy
· Delayed Price · Currency is EUR 107.74
-1.20 (-1.10%)
At close: Dec 3, 2025
Abbott Laboratories Revenue
Abbott Laboratories had revenue of $11.37B USD in the quarter ending September 30, 2025, with 6.90% growth. This brings the company's revenue in the last twelve months to $43.84B, up 6.37% year-over-year. In the year 2024, Abbott Laboratories had annual revenue of $41.95B with 4.59% growth.
Revenue (ttm)
$43.84B
Revenue Growth
+6.37%
P/S Ratio
5.00
Revenue / Employee
$384.59K
Employees
114,000
Market Cap
186.96B EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 41.95B | 1.84B | 4.59% |
| Dec 31, 2023 | 40.11B | -3.54B | -8.12% |
| Dec 31, 2022 | 43.65B | 578.00M | 1.34% |
| Dec 31, 2021 | 43.08B | 8.47B | 24.47% |
| Dec 31, 2020 | 34.61B | 2.70B | 8.48% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UniCredit | 24.85B |
| Intesa Sanpaolo | 25.32B |
| Enel SpA | 77.78B |
| Ferrari | 7.08B |
| Assicurazioni Generali | 56.79B |
| Eni S.p.A. | 86.56B |
| Stellantis | 146.12B |
| Leonardo S.p.a. | 19.13B |